Chemotherapeutics in the treatment of multiple sclerosis
The likely pathogenic mechanisms of multiple sclerosis (MS) provide a sound rationale for investigating the efficacy of drugs possessing immunosuppressive or immunomodulatory properties. With proven efficacy, safety and tolerability, interferon beta formulations and glatiramer acetate have become th...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publishing
2010-09-01
|
| Reeks: | Therapeutic Advances in Neurological Disorders |
| Online toegang: | https://doi.org/10.1177/1756285610379885 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|